Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro.

International journal of molecular medicine - 1 Oct 2007

Sanders Andrew J, Parr Christian, Mason Malcolm D, Jiang Wen G

Abstract excerpt

The hepatocyte growth factor (HGF) pathway has been well documented as playing a vital role in the progression and development of many different types of human cancers; as such this pathway is usually tightly regulated. In cancer cells, the regulation of this pathway has been shown to be disrupte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basement Membrane
Share to Cell Adhesion
Share to Collagen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dextrans

Share to Drug Combinations

Share to Laminin

Share to Proteinase Inhibitory Proteins, Secretory

Share to Proteoglycans

Source

Identifiers

PMID: 17786295

Genes

HGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-17786295-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro.PMID 17786295Read ↗

Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo.Semantic proximity Read ↗

Hepatocyte growth factor activator inhibitor type-1 in cancer: Advances and perspectives (Review)Semantic proximity Read ↗

Genetic upregulation of matriptase‐2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisationSemantic proximity Read ↗

Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathwaySemantic proximity Read ↗

U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3.Semantic proximity Read ↗

SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cellsSemantic proximity Read ↗

The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasisSemantic proximity Read ↗

Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.Semantic proximity Read ↗

The Androgen Receptor Negatively Regulates the Expression of c-Met: Implications for a Novel Mechanism of Prostate Cancer ProgressionSemantic proximity Read ↗

Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate CancerSemantic proximity Read ↗

Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cellsSemantic proximity Read ↗

Resveratrol Suppresses Prostate Cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by Prostate Stromal Cells and Upregulation of E-cadherin by Prostate Cancer Epithelial Cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.